Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...

Semaglutide (Ozempic) was approved for treating type 2 diabetes in 2017, but has since been used as a weight-loss drug. Now, an analysis of Alzheimer’s diagnoses in people who were prescribed ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Originally developed to manage blood sugar in type 2 diabetes, drugs like semaglutide — sold under brand names Ozempic and Wegovy ... safer options beyond current Alzheimer’s drugs ...

REUTERS Other GLP-1 medications include Ozempic, Wegovy, Victoza ... potentially slowing or preventing conditions like ...